Daniel T. Starczynowski
Daniel T. Starczynowski
Verified email at cchmc.org
TitleCited byYear
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2012
Identification of miR-145 and miR-146a as mediators of the 5q–syndrome phenotype
DT Starczynowski, F Kuchenbauer, B Argiropoulos, S Sung, R Morin, ...
Nature medicine 16 (1), 49, 2010
The c-Rel transcription factor and B-cell proliferation: a deal with the devil
TD Gilmore, D Kalaitzidis, MC Liang, DT Starczynowski
Oncogene 23 (13), 2275, 2004
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
DT Starczynowski, WW Lockwood, S Deléhouzée, R Chari, J Wegrzyn, ...
The Journal of clinical investigation 121 (10), 4095-4105, 2011
Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
T Gilmore, ME Gapuzan, D Kalaitzidis, D Starczynowski
Cancer letters 181 (1), 1-9, 2002
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome
GW Rhyasen, L Bolanos, J Fang, A Jerez, M Wunderlich, C Rigolino, ...
Cancer cell 24 (1), 90-104, 2013
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and …
DT Starczynowski, S Vercauteren, A Telenius, S Sung, K Tohyama, ...
Blood 112 (8), 3412-3424, 2008
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations
DT Starczynowski, R Morin, A McPherson, J Lam, R Chari, J Wegrzyn, ...
Blood 117 (2), 595-607, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
F Kuchenbauer, SM Mah, M Heuser, A McPherson, J Rüschmann, ...
Blood 118 (12), 3350-3358, 2011
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
I Gañán-Gómez, Y Wei, DT Starczynowski, S Colla, H Yang, ...
Leukemia 29 (7), 1458, 2015
MicroRNA-146a disrupts hematopoietic differentiation and survival
DT Starczynowski, F Kuchenbauer, J Wegrzyn, A Rouhi, O Petriv, ...
Experimental hematology 39 (2), 167-178. e4, 2011
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1
J Fang, G Rhyasen, L Bolanos, C Rasch, M Varney, M Wunderlich, ...
Blood 120 (4), 858-867, 2012
Deregulation of microRNAs in myelodysplastic syndrome
GW Rhyasen, DT Starczynowski
Leukemia 26 (1), 13, 2012
IRAK signalling in cancer
GW Rhyasen, DT Starczynowski
British journal of cancer 112 (2), 232, 2015
Loss of Tifab, a del (5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor–TRAF6 signaling
ME Varney, M Niederkorn, H Konno, T Matsumura, J Gohda, N Yoshida, ...
Journal of Experimental Medicine 212 (11), 1967-1985, 2015
Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells
DT Starczynowski, JG Reynolds, TD Gilmore
Oncogene 22 (44), 6928, 2003
EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk
IM Wilson, EA Vucic, KSS Enfield, KL Thu, YA Zhang, R Chari, ...
Oncogene 33 (36), 4464, 2014
Innate immune signaling in the myelodysplastic syndromes
DT Starczynowski, A Karsan
Hematology/Oncology Clinics 24 (2), 343-359, 2010
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network
J Fang, B Barker, L Bolanos, X Liu, A Jerez, H Makishima, S Christie, ...
Cell reports 8 (5), 1328-1338, 2014
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia
J Fang, LC Bolanos, K Choi, X Liu, S Christie, S Akunuru, R Kumar, ...
Nature immunology 18 (2), 236, 2017
The system can't perform the operation now. Try again later.
Articles 1–20